Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system

L. Agodoa, C. Anderson, F. Asseibergs, C. Baigent, H. Black, B. Brenner, M. Brown, C. Bulpitt, R. Byington, J. Chalmers, R. Collins, J. Cutler, B. Dahlof, B. Davis, D. De Zeeuw, J. Dens, R. Estacio, R. Fagard, K. Fox, T. FukuiL. Hansson, R. Holman, L. Hunsicker, Y. Imai, M. Ishii, Y. Kanno, J. Kostis, K. Kuramoto, E. Lewis, M. Lièvre, L. H. Lindholm, L. Liu, J. Lubsen, S. Lueders, S. MacMahon, E. Malacco, G. Mancia, M. Matsuzaki, B. Neal, S. Nissen, T. Ohkubo, T. Ogihara, C. Pepine, M. Pfeffer, B. Pitt, P. Poole-Wilson, M. Rahman, W. Remme, G. Remuzzi, A. Rodgers, P. Ruggenenti, T. Saruta, J. Schrader, R. Schrier, P. Sever, P. Sleight, J. Staessen, K. Teo, G. Viberti, J. Wang, P. Whelton, L. Wing, Y. Yui, S. Yusuf, A. Zanchetti, F. Turnbull, B. Neal, M. Pfeffer, J. Kostis, C. Algert, M. Woodward, J. Chalmers, A. Zanchetti, S. MacMahon

Research output: Contribution to journalArticle

301 Citations (Scopus)

Abstract

OBJECTIVES: To evaluate the blood pressure-dependent and independent effects of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) on major cardiovascular events. METHODS: Using data from 26 large-scale trials comparing an ACEI or an ARB with placebo or another drug class, meta-regression analyses were conducted in which treatment-specific relative risks for major cause-specific outcomes [stroke, major coronary heart disease (CHD) events and heart failure] were regressed against follow-up blood pressure differences. RESULTS: From a total of 146 838 individuals with high blood pressure or an elevated risk of cardiovascular disease, 22 666 major cardiovascular events were documented during follow-up. The analyses showed comparable blood pressure-dependent reductions in risk with ACEI and ARB (P ≥ 0.3 for all three outcomes). The analyses also showed that ACEI produced a blood pressure-independent reduction in the relative risk of CHD of approximately 9% (95% confidence interval 3-14%). No similar effect was detected for ARB, and there was some evidence of a difference between ACEI and ARB in this regard (P = 0.002). For both stroke and heart failure there was no evidence of any blood pressure-independent effects of either ACEI or ARB. CONCLUSION: There are similar blood pressure-dependent effects of ACEI and ARB for the risks of stroke, CHD and heart failure. For ACEI, but not ARB, there is evidence of blood pressure-independent effects on the risk of major coronary disease events.

Original languageEnglish
Pages (from-to)951-958
Number of pages8
JournalJournal of Hypertension
Volume25
Issue number5
DOIs
Publication statusPublished - May 2007

Fingerprint

Angiotensin Receptor Antagonists
Renin-Angiotensin System
Angiotensin-Converting Enzyme Inhibitors
Blood Pressure
Coronary Disease
Heart Failure
Stroke
Risk Reduction Behavior
Meta-Analysis
Cardiovascular Diseases
Placebos
Regression Analysis
Confidence Intervals
Hypertension
Pharmaceutical Preparations

Keywords

  • Blood pressure
  • Coronary heart disease
  • Heart failure
  • Meta-regression analyses
  • Metaanalyses
  • Stroke

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

Agodoa, L., Anderson, C., Asseibergs, F., Baigent, C., Black, H., Brenner, B., ... MacMahon, S. (2007). Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. Journal of Hypertension, 25(5), 951-958. https://doi.org/10.1097/HJH.0b013e3280bad9b4

Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. / Agodoa, L.; Anderson, C.; Asseibergs, F.; Baigent, C.; Black, H.; Brenner, B.; Brown, M.; Bulpitt, C.; Byington, R.; Chalmers, J.; Collins, R.; Cutler, J.; Dahlof, B.; Davis, B.; De Zeeuw, D.; Dens, J.; Estacio, R.; Fagard, R.; Fox, K.; Fukui, T.; Hansson, L.; Holman, R.; Hunsicker, L.; Imai, Y.; Ishii, M.; Kanno, Y.; Kostis, J.; Kuramoto, K.; Lewis, E.; Lièvre, M.; Lindholm, L. H.; Liu, L.; Lubsen, J.; Lueders, S.; MacMahon, S.; Malacco, E.; Mancia, G.; Matsuzaki, M.; Neal, B.; Nissen, S.; Ohkubo, T.; Ogihara, T.; Pepine, C.; Pfeffer, M.; Pitt, B.; Poole-Wilson, P.; Rahman, M.; Remme, W.; Remuzzi, G.; Rodgers, A.; Ruggenenti, P.; Saruta, T.; Schrader, J.; Schrier, R.; Sever, P.; Sleight, P.; Staessen, J.; Teo, K.; Viberti, G.; Wang, J.; Whelton, P.; Wing, L.; Yui, Y.; Yusuf, S.; Zanchetti, A.; Turnbull, F.; Neal, B.; Pfeffer, M.; Kostis, J.; Algert, C.; Woodward, M.; Chalmers, J.; Zanchetti, A.; MacMahon, S.

In: Journal of Hypertension, Vol. 25, No. 5, 05.2007, p. 951-958.

Research output: Contribution to journalArticle

Agodoa, L, Anderson, C, Asseibergs, F, Baigent, C, Black, H, Brenner, B, Brown, M, Bulpitt, C, Byington, R, Chalmers, J, Collins, R, Cutler, J, Dahlof, B, Davis, B, De Zeeuw, D, Dens, J, Estacio, R, Fagard, R, Fox, K, Fukui, T, Hansson, L, Holman, R, Hunsicker, L, Imai, Y, Ishii, M, Kanno, Y, Kostis, J, Kuramoto, K, Lewis, E, Lièvre, M, Lindholm, LH, Liu, L, Lubsen, J, Lueders, S, MacMahon, S, Malacco, E, Mancia, G, Matsuzaki, M, Neal, B, Nissen, S, Ohkubo, T, Ogihara, T, Pepine, C, Pfeffer, M, Pitt, B, Poole-Wilson, P, Rahman, M, Remme, W, Remuzzi, G, Rodgers, A, Ruggenenti, P, Saruta, T, Schrader, J, Schrier, R, Sever, P, Sleight, P, Staessen, J, Teo, K, Viberti, G, Wang, J, Whelton, P, Wing, L, Yui, Y, Yusuf, S, Zanchetti, A, Turnbull, F, Neal, B, Pfeffer, M, Kostis, J, Algert, C, Woodward, M, Chalmers, J, Zanchetti, A & MacMahon, S 2007, 'Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system', Journal of Hypertension, vol. 25, no. 5, pp. 951-958. https://doi.org/10.1097/HJH.0b013e3280bad9b4
Agodoa, L. ; Anderson, C. ; Asseibergs, F. ; Baigent, C. ; Black, H. ; Brenner, B. ; Brown, M. ; Bulpitt, C. ; Byington, R. ; Chalmers, J. ; Collins, R. ; Cutler, J. ; Dahlof, B. ; Davis, B. ; De Zeeuw, D. ; Dens, J. ; Estacio, R. ; Fagard, R. ; Fox, K. ; Fukui, T. ; Hansson, L. ; Holman, R. ; Hunsicker, L. ; Imai, Y. ; Ishii, M. ; Kanno, Y. ; Kostis, J. ; Kuramoto, K. ; Lewis, E. ; Lièvre, M. ; Lindholm, L. H. ; Liu, L. ; Lubsen, J. ; Lueders, S. ; MacMahon, S. ; Malacco, E. ; Mancia, G. ; Matsuzaki, M. ; Neal, B. ; Nissen, S. ; Ohkubo, T. ; Ogihara, T. ; Pepine, C. ; Pfeffer, M. ; Pitt, B. ; Poole-Wilson, P. ; Rahman, M. ; Remme, W. ; Remuzzi, G. ; Rodgers, A. ; Ruggenenti, P. ; Saruta, T. ; Schrader, J. ; Schrier, R. ; Sever, P. ; Sleight, P. ; Staessen, J. ; Teo, K. ; Viberti, G. ; Wang, J. ; Whelton, P. ; Wing, L. ; Yui, Y. ; Yusuf, S. ; Zanchetti, A. ; Turnbull, F. ; Neal, B. ; Pfeffer, M. ; Kostis, J. ; Algert, C. ; Woodward, M. ; Chalmers, J. ; Zanchetti, A. ; MacMahon, S. / Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. In: Journal of Hypertension. 2007 ; Vol. 25, No. 5. pp. 951-958.
@article{4894b267a56f4aa8ab879270b439e2ca,
title = "Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system",
abstract = "OBJECTIVES: To evaluate the blood pressure-dependent and independent effects of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) on major cardiovascular events. METHODS: Using data from 26 large-scale trials comparing an ACEI or an ARB with placebo or another drug class, meta-regression analyses were conducted in which treatment-specific relative risks for major cause-specific outcomes [stroke, major coronary heart disease (CHD) events and heart failure] were regressed against follow-up blood pressure differences. RESULTS: From a total of 146 838 individuals with high blood pressure or an elevated risk of cardiovascular disease, 22 666 major cardiovascular events were documented during follow-up. The analyses showed comparable blood pressure-dependent reductions in risk with ACEI and ARB (P ≥ 0.3 for all three outcomes). The analyses also showed that ACEI produced a blood pressure-independent reduction in the relative risk of CHD of approximately 9{\%} (95{\%} confidence interval 3-14{\%}). No similar effect was detected for ARB, and there was some evidence of a difference between ACEI and ARB in this regard (P = 0.002). For both stroke and heart failure there was no evidence of any blood pressure-independent effects of either ACEI or ARB. CONCLUSION: There are similar blood pressure-dependent effects of ACEI and ARB for the risks of stroke, CHD and heart failure. For ACEI, but not ARB, there is evidence of blood pressure-independent effects on the risk of major coronary disease events.",
keywords = "Blood pressure, Coronary heart disease, Heart failure, Meta-regression analyses, Metaanalyses, Stroke",
author = "L. Agodoa and C. Anderson and F. Asseibergs and C. Baigent and H. Black and B. Brenner and M. Brown and C. Bulpitt and R. Byington and J. Chalmers and R. Collins and J. Cutler and B. Dahlof and B. Davis and {De Zeeuw}, D. and J. Dens and R. Estacio and R. Fagard and K. Fox and T. Fukui and L. Hansson and R. Holman and L. Hunsicker and Y. Imai and M. Ishii and Y. Kanno and J. Kostis and K. Kuramoto and E. Lewis and M. Li{\`e}vre and Lindholm, {L. H.} and L. Liu and J. Lubsen and S. Lueders and S. MacMahon and E. Malacco and G. Mancia and M. Matsuzaki and B. Neal and S. Nissen and T. Ohkubo and T. Ogihara and C. Pepine and M. Pfeffer and B. Pitt and P. Poole-Wilson and M. Rahman and W. Remme and G. Remuzzi and A. Rodgers and P. Ruggenenti and T. Saruta and J. Schrader and R. Schrier and P. Sever and P. Sleight and J. Staessen and K. Teo and G. Viberti and J. Wang and P. Whelton and L. Wing and Y. Yui and S. Yusuf and A. Zanchetti and F. Turnbull and B. Neal and M. Pfeffer and J. Kostis and C. Algert and M. Woodward and J. Chalmers and A. Zanchetti and S. MacMahon",
year = "2007",
month = "5",
doi = "10.1097/HJH.0b013e3280bad9b4",
language = "English",
volume = "25",
pages = "951--958",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system

AU - Agodoa, L.

AU - Anderson, C.

AU - Asseibergs, F.

AU - Baigent, C.

AU - Black, H.

AU - Brenner, B.

AU - Brown, M.

AU - Bulpitt, C.

AU - Byington, R.

AU - Chalmers, J.

AU - Collins, R.

AU - Cutler, J.

AU - Dahlof, B.

AU - Davis, B.

AU - De Zeeuw, D.

AU - Dens, J.

AU - Estacio, R.

AU - Fagard, R.

AU - Fox, K.

AU - Fukui, T.

AU - Hansson, L.

AU - Holman, R.

AU - Hunsicker, L.

AU - Imai, Y.

AU - Ishii, M.

AU - Kanno, Y.

AU - Kostis, J.

AU - Kuramoto, K.

AU - Lewis, E.

AU - Lièvre, M.

AU - Lindholm, L. H.

AU - Liu, L.

AU - Lubsen, J.

AU - Lueders, S.

AU - MacMahon, S.

AU - Malacco, E.

AU - Mancia, G.

AU - Matsuzaki, M.

AU - Neal, B.

AU - Nissen, S.

AU - Ohkubo, T.

AU - Ogihara, T.

AU - Pepine, C.

AU - Pfeffer, M.

AU - Pitt, B.

AU - Poole-Wilson, P.

AU - Rahman, M.

AU - Remme, W.

AU - Remuzzi, G.

AU - Rodgers, A.

AU - Ruggenenti, P.

AU - Saruta, T.

AU - Schrader, J.

AU - Schrier, R.

AU - Sever, P.

AU - Sleight, P.

AU - Staessen, J.

AU - Teo, K.

AU - Viberti, G.

AU - Wang, J.

AU - Whelton, P.

AU - Wing, L.

AU - Yui, Y.

AU - Yusuf, S.

AU - Zanchetti, A.

AU - Turnbull, F.

AU - Neal, B.

AU - Pfeffer, M.

AU - Kostis, J.

AU - Algert, C.

AU - Woodward, M.

AU - Chalmers, J.

AU - Zanchetti, A.

AU - MacMahon, S.

PY - 2007/5

Y1 - 2007/5

N2 - OBJECTIVES: To evaluate the blood pressure-dependent and independent effects of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) on major cardiovascular events. METHODS: Using data from 26 large-scale trials comparing an ACEI or an ARB with placebo or another drug class, meta-regression analyses were conducted in which treatment-specific relative risks for major cause-specific outcomes [stroke, major coronary heart disease (CHD) events and heart failure] were regressed against follow-up blood pressure differences. RESULTS: From a total of 146 838 individuals with high blood pressure or an elevated risk of cardiovascular disease, 22 666 major cardiovascular events were documented during follow-up. The analyses showed comparable blood pressure-dependent reductions in risk with ACEI and ARB (P ≥ 0.3 for all three outcomes). The analyses also showed that ACEI produced a blood pressure-independent reduction in the relative risk of CHD of approximately 9% (95% confidence interval 3-14%). No similar effect was detected for ARB, and there was some evidence of a difference between ACEI and ARB in this regard (P = 0.002). For both stroke and heart failure there was no evidence of any blood pressure-independent effects of either ACEI or ARB. CONCLUSION: There are similar blood pressure-dependent effects of ACEI and ARB for the risks of stroke, CHD and heart failure. For ACEI, but not ARB, there is evidence of blood pressure-independent effects on the risk of major coronary disease events.

AB - OBJECTIVES: To evaluate the blood pressure-dependent and independent effects of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) on major cardiovascular events. METHODS: Using data from 26 large-scale trials comparing an ACEI or an ARB with placebo or another drug class, meta-regression analyses were conducted in which treatment-specific relative risks for major cause-specific outcomes [stroke, major coronary heart disease (CHD) events and heart failure] were regressed against follow-up blood pressure differences. RESULTS: From a total of 146 838 individuals with high blood pressure or an elevated risk of cardiovascular disease, 22 666 major cardiovascular events were documented during follow-up. The analyses showed comparable blood pressure-dependent reductions in risk with ACEI and ARB (P ≥ 0.3 for all three outcomes). The analyses also showed that ACEI produced a blood pressure-independent reduction in the relative risk of CHD of approximately 9% (95% confidence interval 3-14%). No similar effect was detected for ARB, and there was some evidence of a difference between ACEI and ARB in this regard (P = 0.002). For both stroke and heart failure there was no evidence of any blood pressure-independent effects of either ACEI or ARB. CONCLUSION: There are similar blood pressure-dependent effects of ACEI and ARB for the risks of stroke, CHD and heart failure. For ACEI, but not ARB, there is evidence of blood pressure-independent effects on the risk of major coronary disease events.

KW - Blood pressure

KW - Coronary heart disease

KW - Heart failure

KW - Meta-regression analyses

KW - Metaanalyses

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=34147116836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147116836&partnerID=8YFLogxK

U2 - 10.1097/HJH.0b013e3280bad9b4

DO - 10.1097/HJH.0b013e3280bad9b4

M3 - Article

C2 - 17414657

AN - SCOPUS:34147116836

VL - 25

SP - 951

EP - 958

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 5

ER -